Showing results (81-90 of 265) with videos related to
Sort By:
Pageof 27
Lymphokine and Cytokine Research|June 1, 1992
Interleukin-6 protects ductal breast carcinoma cells from MHC-unrestricted cell-mediated cytotoxicityZ Reiter, L Chen, M Revel, et al.Ergonomics|May 1, 1989
Strength and cross-sectional area of the dorsal neck musclesM A Mayoux-Benhamou, M Wybier, M RevelArchives of Physical Medicine and Rehabilitation|March 10, 2001
Pelvic mobility when bending forward in standing position: validity and reliability of 2 motion analysis devicesC Perret, S Poiraudeau, J Fermanian, et al.Cytokines, Cellular & Molecular Therapy|March 6, 1999
Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimeraA Katz, J Chebath, J Friedman, et al.Nucleic Acids Research|September 25, 1984
A human IFN-beta 1 gene deleted of promoter sequences upstream from the TATA box is controlled post-transcriptionally by dsRNAU Nir, B Cohen, L Chen, et al.The Journal of Biological Chemistry|June 25, 1987
The human interferon-gamma receptor. Purification, characterization, and preparation of antibodiesD Novick, P Orchansky, M Revel, et al.The EMBO Journal|September 1, 1985
Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequencesP Benech, Y Mory, M Revel, et al.Nature|December 10, 1987
Constitutive expression of (2'-5') oligo A synthetase confers resistance to picornavirus infectionJ Chebath, P Benech, M Revel, et al.Nucleic Acids Research|September 11, 1995
5' upstream sequences of MyD88, an IL-6 primary response gene in M1 cells: detection of functional IRF-1 and Stat factors binding sitesS Harroch, Y Gothelf, M Revel, et al.FEBS Letters|November 7, 1988
Recombinant interferon-beta 2 (interleukin-6) induces myeloid differentiationL Chen, D Novick, M Rubinstein, et al.Pageof 27